News & Analysis on Clinical Trial Services & Contract Research And Development
BioMoti and Pharmidex have received funding to advance proof-of-concept precision medicine studies – which if successful, could help secure pharma partnerships or additional investment, says BioMoti CEO.
Update
Novum Pharmaceutical Research Services has completed several upgrades at its Las Vegas, Nevada clinical facility, which opened in 2004.
KCR has joined the Massachusetts Biotechnology Council – a “must” for the CRO as it continues to strengthen its footprint in the US market, says CEO.
The global contract development and manufacturing organization (CDMO) has launched its Almac Pod service solution in the US after introducing it in Europe last year.
The European Medicines Agency (EMA) has announced it will launch an updated version of information system EudraVigilance to better monitor suspected adverse reactions to medicines.
The US FDA has called for industry comments on its planned procedures for the scheduling and conduct of post-complete response letter (CRL) meetings.
Cambrex Corporation has announced plans to start making high potency APIs at its plant in Milan, Italy citing impending patent losses for small molecule drugs as an opportunity.
CordenPharma has invested in its Swiss API development services a week after buying a manufacturing plant from Pfizer.